BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19016532)

  • 1. Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC.
    Chen N; Sun W; Deng X; Hao Y; Chen X; Xing B; Jia W; Ma J; Wei H; Zhu Y; Qian X; Jiang Y; He F
    Proteomics; 2008 Dec; 8(23-24):5108-18. PubMed ID: 19016532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential analysis of tyrosine-phosphorylated proteins in human hepatocellular carcinoma cell lines with different metastasis potentials].
    Zhang LJ; Cui JF; Liu YK; Zhu YS; Song HY; Shen HL; Feng JT; Dai Z; Chen J; Sun RX
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):436-9. PubMed ID: 15975278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomic signature of liver cancer cells: tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma.
    Sun Y; Mi W; Cai J; Ying W; Liu F; Lu H; Qiao Y; Jia W; Bi X; Lu N; Liu S; Qian X; Zhao X
    J Proteome Res; 2008 Sep; 7(9):3847-59. PubMed ID: 18646787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transcription factor activity profile of human hepatocellular carcinoma cell lines with different metastatic potentials].
    Pan Q; Wang L; Sun HC; Liu YK; Ye SL; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):37-40. PubMed ID: 16420763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the SILAC (stable isotope labelling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression.
    Xu Y; Liang S; Shen G; Xu X; Liu Q; Xu Z; Gong F; Tang M; Wei Y
    Biotechnol Appl Biochem; 2009 Jul; 54(1):11-20. PubMed ID: 19250064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
    Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
    Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
    Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
    Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues].
    Song HY; Liu YK; Cui JF; Zhang LJ; Dai Z; Feng JT; Feng JX; Shen HL; Yang PY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):331-4. PubMed ID: 15918964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials].
    Xue TC; Chen RX; Ye SL; Sun RX; Chen J; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):261-5. PubMed ID: 17456312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.
    Long X; Zhang J; Zhang Y; Yao J; Cai Z; Yang P
    Mol Biosyst; 2011 May; 7(5):1728-41. PubMed ID: 21423987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target.
    Lee TK; Man K; Ho JW; Wang XH; Poon RT; Sun CK; Ng KT; Ng IO; Xu R; Fan ST
    Carcinogenesis; 2005 Mar; 26(3):681-7. PubMed ID: 15604094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
    Yu Y; Shen H; Yu H; Zhong F; Zhang Y; Zhang C; Zhao J; Li H; Chen J; Liu Y; Yang P
    Mol Biosyst; 2011 Jun; 7(6):1908-16. PubMed ID: 21468425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protein profiles of multinodular hepatocellular carcinoma with multicentric occurrence or with intrahepatic metastasis].
    LI M; GUO K; KANG XN; SUN L; SHU H; LI RL; XU MH; LIU YK; QIN X; LI S
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):354-8. PubMed ID: 19497201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis.
    Luque-García JL; Martínez-Torrecuadrada JL; Epifano C; Cañamero M; Babel I; Casal JI
    Proteomics; 2010 Mar; 10(5):940-52. PubMed ID: 20049862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
    Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
    Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma.
    Shengbing Z; Feng LJ; Bin W; Lingyun G; Aimin H
    Anat Rec (Hoboken); 2009 Aug; 292(8):1128-34. PubMed ID: 19645016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
    Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
    Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.